PSA May Be Insufficient to Detect Early Prostate Cancer in Transgender Women ( ascopost.com )
Transgender women receiving hormone therapy may skew artificially low on prostate cancer screening tests, thereby providing false reassurance and potentially delaying diagnosis and treatment, according to a recent study published by Nik-Ahd et al in JAMA. The findings indicated that transgender women and physicians should interpret standard screening guidelines with caution.